Tonix Pharmaceuticals Holding Corp. (TNXP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.41M |
| Enterprise value | -11.94M |
| Trailing P/E | 0.29 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.09 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.21 |
| 52-week change 3 | -77.66% |
| S&P500 52-week change 3 | 19.21% |
| 52-week high 3 | 9.8125 |
| 52-week low 3 | 0.6801 |
| 50-day moving average 3 | 1.0388 |
| 200-day moving average 3 | 2.9112 |
Share statistics
| Avg vol (3-month) 3 | 404.04k |
| Avg vol (10-day) 3 | 201.94k |
| Shares outstanding 5 | 17.76M |
| Implied shares outstanding 6 | 17.76M |
| Float 8 | 17.76M |
| % held by insiders 1 | 0.04% |
| % held by institutions 1 | 11.94% |
| Shares short (14 Sept 2023) 4 | 105.5k |
| Short ratio (14 Sept 2023) 4 | 0.57 |
| Short % of float (14 Sept 2023) 4 | 0.59% |
| Short % of shares outstanding (14 Sept 2023) 4 | 0.59% |
| Shares short (prior month 14 Aug 2023) 4 | 458.19k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 31 Oct 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 16:100 |
| Last split date 3 | 09 May 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 June 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -35.91% |
| Return on equity (ttm) | -60.97% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -122.32M |
| Net income avi to common (ttm) | -124.43M |
| Diluted EPS (ttm) | -8.5600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 25.62M |
| Total cash per share (mrq) | 1.44 |
| Total debt (mrq) | 1.27M |
| Total debt/equity (mrq) | 0.90% |
| Current ratio (mrq) | 2.78 |
| Book value per share (mrq) | 13.05 |
Cash flow statement
| Operating cash flow (ttm) | -102.11M |
| Levered free cash flow (ttm) | -60.62M |
© 2023 Yahoo. All rights reserved.
